Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery.

Chromatin variation associated with liver metabolism is mediated by transposable elements. Epigenetics Chromatin (2016) 1.38

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract (2011) 15.13

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

How do we define cure of diabetes? Diabetes Care (2009) 3.59

Insulin degradation: progress and potential. Endocr Rev (1998) 3.57

Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg (2005) 2.59

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature (1995) 2.54

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab (2011) 1.86

Bariatric surgery for type 2 diabetes. Lancet (2012) 1.86

Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes (2005) 1.73

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes (2000) 1.62

Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56

Regulation of insulin receptor function. Cell Mol Life Sci (2007) 1.38

Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37

Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab (2010) 1.25

Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes (2005) 1.24

Long-term outcomes after gastric bypass. Obes Surg (2005) 1.18

Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab (2005) 1.14

Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev (2010) 1.06

Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia (1997) 1.04

Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM. Am J Physiol (1993) 1.00

Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg (2006) 0.98

No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes (1999) 0.97

Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes (1998) 0.95

Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur J Pharmacol (2009) 0.90

Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord (2004) 0.87

PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia (1996) 0.85

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling. Biochim Biophys Acta (2013) 0.84

Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats. J Appl Physiol (1985) (2001) 0.83

Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery. Obes Surg (2011) 0.82

Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance. Clin Endocrinol (Oxf) (1997) 0.80

Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation. Metabolism (2003) 0.80

Insulin modulates PC-1 processing and recruitment in cultured human cells. Am J Physiol Endocrinol Metab (2002) 0.80

Metabolic characteristics of patients with apparently normal fasting plasma glucose. N Z Med J (2006) 0.79

Hepatic ENPP1 expression is induced in diabetic rabbits. Mamm Genome (2006) 0.78

Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev (2000) 0.77

ENPP1 mRNA levels in white blood cells and prediction of metformin efficacy in type 2 diabetic patients: a preliminary evidence. Nutr Metab Cardiovasc Dis (2011) 0.76